over $1b revenue and more than 40% margin, page-35

I'll have to strain my brain to recall that one Globbens.

Unitract took over Integrated Bio-sciences (IBS) back in 2006.

Only after that were there any murmurings of something bigger, as the main game was on the Unitract 1ml syringe at the time.

In July 2008, the IA with Sanofi was announced, and funding was based upon milestones met, on a quarterly basis.

Then the Unifill was announced, and the rest was slow moving history!

I may have missed that imminent contract deal that you mentioned, but I don't think so.

Does anyone else remember?



dino